MUC1-C: The Occam Razor of Osimertinib Resistance?

J Thorac Oncol. 2024 Mar;19(3):370-372. doi: 10.1016/j.jtho.2023.12.014.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Acrylamides / pharmacology
  • Aniline Compounds / pharmacology
  • Carcinoma, Non-Small-Cell Lung*
  • Cell Line, Tumor
  • Drug Resistance, Neoplasm
  • Humans
  • Indoles*
  • Lung Neoplasms* / drug therapy
  • Lung Neoplasms* / genetics
  • Mucin-1
  • Mutation
  • Protein Kinase Inhibitors / pharmacology
  • Pyrimidines

Substances

  • osimertinib
  • Pyrimidines
  • Acrylamides
  • Aniline Compounds
  • Protein Kinase Inhibitors
  • MUC1 protein, human
  • Mucin-1
  • Indoles